Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 51
Filter
Add more filters

Publication year range
1.
Medicina (Kaunas) ; 56(3)2020 Mar 13.
Article in English | MEDLINE | ID: mdl-32183092

ABSTRACT

Background and Objectives: One of the most frequent genetic alterations reported to date in prostate cancer (PC) is aberrant methylation of glutathione transferase P1 (GSTP1). Taking into consideration the involvement of oxidative stress in PC pathogenesis and recent advances in scientific understanding of the role of GSTP1*Ala114Val rs1138272 polymorphism in carcinogenesis, we hypothesized that this single-nucleotide polymorphism (SNP) influences the risk of PC independently of, or in combination with, other GST polymorphisms, including GSTP1*IIe105Val rs1695 or GSTM1 and GSTT1 deletion polymorphisms. Materials and Methods: Genotyping was performed in 237 PC cases and in 236 age-matched controls by multiplex polymerase chain reaction (PCR) for deletion of GST polymorphisms and by quantitative PCR for SNPs. Results: We found that carriers of either GSTP1*Val (rs1138272) or GSTP1*Val (rs1695) variant alleles had a PC risk compared to individuals with both referent alleles (OR = 4.93, 95%CI: 2.89-8.40, p < 0.001 and OR = 1.8, 95%CI: 1.19-2.73, p = 0.006, respectively). Additionally, in a haplotype analysis we found that individuals with GSTP1*C haplotype, represented by both variant alleles (GSTP1*Val rs1695 + GSTP1*Val rs1138272), had a 5.46 times higher risk of PC development compared to individuals with the most frequent haplotype (95%CI = 2.56-11.65, p < 0.001), suggesting a potential role of those variants in PC susceptibility. A regression analysis on the number of risk-associated alleles per individual (GSTM1*active, GSTT1*null, GSTP1*Val rs1695 and GSTP1*Val rs1138272) showed a significant increase in the risk of developing PC, from 3.65-fold in carriers of two risk alleles (95%CI = 1.55-8.61, p = 0.003) to an approximately 12-fold increase in carriers of all four risk alleles (95%CI = 3.05-44.93, p < 0.001). Conclusion: Prostate cancer may be influenced by multiple glutathione transferase (GST) polymorphic genes, especially GSTP1, highlighting the role of gene-gene interactions in human susceptibility to this cancer.


Subject(s)
Glutathione S-Transferase pi/analysis , Polymorphism, Genetic/genetics , Prostatic Neoplasms/genetics , Aged , Case-Control Studies , Genetic Predisposition to Disease , Glutathione S-Transferase pi/blood , Humans , Male , Middle Aged , Prostatic Neoplasms/diagnosis , Prostatic Neoplasms/physiopathology , Risk Adjustment/methods , Serbia
2.
Prostate ; 79(14): 1705-1714, 2019 10.
Article in English | MEDLINE | ID: mdl-31433512

ABSTRACT

BACKGROUND: We identify and validate accurate diagnostic biomarkers for prostate cancer through a systematic evaluation of DNA methylation alterations. MATERIALS AND METHODS: We assembled three early prostate cancer cohorts (total patients = 699) from which we collected and processed over 1300 prostatectomy tissue samples for DNA extraction. Using real-time methylation-specific PCR, we measured normalized methylation levels at 15 frequently methylated loci. After partitioning sample sets into independent training and validation cohorts, classifiers were developed using logistic regression, analyzed, and validated. RESULTS: In the training dataset, DNA methylation levels at 7 of 15 genomic loci (glutathione S-transferase Pi 1 [GSTP1], CCDC181, hyaluronan, and proteoglycan link protein 3 [HAPLN3], GSTM2, growth arrest-specific 6 [GAS6], RASSF1, and APC) showed large differences between cancer and benign samples. The best binary classifier was the GAS6/GSTP1/HAPLN3 logistic regression model, with an area under these curves of 0.97, which showed a sensitivity of 94%, and a specificity of 93% after external validation. CONCLUSION: We created and validated a multigene model for the classification of benign and malignant prostate tissue. With false positive and negative rates below 7%, this three-gene biomarker represents a promising basis for more accurate prostate cancer diagnosis.


Subject(s)
Biomarkers, Tumor , DNA Methylation/genetics , Prostatic Neoplasms/classification , Prostatic Neoplasms/pathology , DNA/isolation & purification , Epigenesis, Genetic , Extracellular Matrix Proteins/analysis , Extracellular Matrix Proteins/genetics , Glutathione S-Transferase pi/analysis , Glutathione S-Transferase pi/genetics , Humans , Intercellular Signaling Peptides and Proteins/analysis , Intercellular Signaling Peptides and Proteins/genetics , Male , Prostatic Neoplasms/chemistry , Proteoglycans/analysis , Proteoglycans/genetics , Reproducibility of Results , Sensitivity and Specificity
3.
Crit Care ; 22(1): 108, 2018 Apr 26.
Article in English | MEDLINE | ID: mdl-29699579

ABSTRACT

BACKGROUND: Acute kidney injury (AKI) after cardiovascular surgery is a serious complication. Little is known about the ability of novel biomarkers in combination with clinical risk scores for prediction of advanced AKI. METHODS: In this prospectively conducted multicenter study, urine samples were collected from 149 adults at 0, 3, 6, 12 and 24 h after cardiovascular surgery. We measured urinary hemojuvelin (uHJV), kidney injury molecule-1 (uKIM-1), neutrophil gelatinase-associated lipocalin (uNGAL), α-glutathione S-transferase (uα-GST) and π-glutathione S-transferase (uπ-GST). The primary outcome was advanced AKI, under the definition of Kidney Disease: Improving Global Outcomes (KDIGO) stage 2, 3 and composite outcomes were KDIGO stage 2, 3 or 90-day mortality after hospital discharge. RESULTS: Patients with advanced AKI had significantly higher levels of uHJV and uKIM-1 at 3, 6 and 12 h after surgery. When normalized by urinary creatinine level, uKIM-1 in combination with uHJV at 3 h post-surgery had a high predictive ability for advanced AKI and composite outcome (AUC = 0.898 and 0.905, respectively). The combination of this biomarker panel (normalized uKIM-1, uHJV at 3 h post-operation) and Liano's score was superior in predicting advanced AKI (AUC = 0.931, category-free net reclassification improvement of 1.149, and p <  0.001). CONCLUSIONS: When added to Liano's score, normalized uHJV and uKIM-1 levels at 3 h after cardiovascular surgery enhanced the identification of patients at higher risk of progression to advanced AKI and composite outcomes.


Subject(s)
Biomarkers/analysis , Acute Kidney Injury/mortality , Acute Kidney Injury/physiopathology , Adult , Aged , Analysis of Variance , Biomarkers/urine , Cardiac Surgical Procedures , Chi-Square Distribution , Female , GPI-Linked Proteins/analysis , GPI-Linked Proteins/urine , Glutathione S-Transferase pi/analysis , Glutathione S-Transferase pi/urine , Glutathione Transferase/analysis , Glutathione Transferase/urine , Hemochromatosis Protein , Hepatitis A Virus Cellular Receptor 1/analysis , Hospital Mortality , Humans , Intensive Care Units/organization & administration , Intensive Care Units/statistics & numerical data , Isoenzymes/analysis , Isoenzymes/urine , Lipocalin-2/analysis , Lipocalin-2/urine , Male , Middle Aged , Organ Dysfunction Scores , Prospective Studies , ROC Curve , Statistics, Nonparametric , Taiwan
4.
Acta Derm Venereol ; 95(1): 40-4, 2015 Jan.
Article in English | MEDLINE | ID: mdl-24535144

ABSTRACT

The detoxifying enzyme glutathione-s-transferase pi (GST-π) is present in keratinocytes and melanocytes and exerts a protective role against tumour progression. Melanomas close to melanocytic naevus remnants occur less frequently on sun-exposed areas, whereas solar dermal elastosis, hallmark of chronic sun-damage, characterise melanomas on sun-exposed skin. We evaluated the expression of GST-π in 113 melanomas associated to melanocytic naevus remnants or to solar dermal elastosis, classified according to clinical characteristics, history of sun exposure, histological subtypes and AJCC staging. Chronically sun-damaged melanomas, identified by moderate-severe solar dermal elastosis, showed a lower nuclear GST-π expression and a higher thickness than those related to melanocytic naevus remnants (p < 0.03). Multivariate logistic regression analysis demonstrated that male gender and chronic sun-exposure are independent risk factors significantly associated to melanomas localised on the trunk (OR = 3.36, 95% CI: 1.31-8.65; OR = 5.97, 95% CI: 1.71-20.87). If confirmed on a larger series, lower expression of nuclear GST-π in melanoma cells could represent a possible marker of chronically sun-damaged melanoma pathogenesis.


Subject(s)
Biomarkers, Tumor/analysis , Glutathione S-Transferase pi/analysis , Melanoma/enzymology , Melanoma/epidemiology , Neoplasms, Radiation-Induced/enzymology , Neoplasms, Radiation-Induced/epidemiology , Nevus, Pigmented/enzymology , Nevus, Pigmented/epidemiology , Sunlight/adverse effects , Adult , Aged , Biopsy , Chi-Square Distribution , Down-Regulation , Female , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Neoplastic , Humans , Immunohistochemistry , Italy/epidemiology , Logistic Models , Male , Melanoma/pathology , Middle Aged , Multivariate Analysis , Neoplasm Staging , Neoplasms, Radiation-Induced/pathology , Nevus, Pigmented/pathology , Odds Ratio , Risk Factors , Sex Factors , Time Factors
5.
Thorac Cardiovasc Surg ; 63(2): 152-7, 2015 Mar.
Article in English | MEDLINE | ID: mdl-24647742

ABSTRACT

BACKGROUND: Aortic aneurysms are vascular diseases that are associated with high mortality and morbidity. Cytochrome P450 CYP1A1 and glutathione S-transferase (GSTP1) isozymes were searched and compared with the patients who had experienced aortic surgery due to aortic aneurysm and atherosclerotic patients without aneurysm to find the relation of the oxidative stress with the aneurysms. MATERIALS AND METHODS: Study group consisted of the patients with the diagnosis of aortic aneurysm (group I, n: 12) and control group who were operated for coronary bypass surgery: preoperatively drug users (group II, n: 21) and nonusers (group III, n: 15). Paraffin sections (4 µm thick) of aortic biopsy materials were stained with hematoxylin and eosine, CYP1A1 and GSTP1 immunohistochemical markers. The specimens were evaluated using light microscopy at 40- to 400-fold magnification. RESULTS: The expressions of CYP1A1 and GSTP1 isozymes were found statistically significantly higher in the patients who have an aortic aneurysm than both the control groups (p < 0.05). There was no significant association between protein expressions, drugs and duration of usage, patient's demographic variables, and smoking (p > 0.05). CONCLUSIONS: In this pioneering study, CYP1A1 and GSTP1 isozymes are related with the aneurysms. The strategy that prevents the oxidative stress for the patients who had aortic aneurysms could be a valuable choice of searching to effect the aneurysmal progression.


Subject(s)
Aorta/enzymology , Aortic Aneurysm/enzymology , Cytochrome P-450 CYP1A1/analysis , Glutathione S-Transferase pi/analysis , Aged , Aorta/pathology , Aorta/surgery , Aortic Aneurysm/diagnosis , Aortic Aneurysm/surgery , Biopsy , Case-Control Studies , Female , Humans , Immunohistochemistry , Male , Middle Aged , Up-Regulation
6.
Cancer Sci ; 105(10): 1369-76, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25155055

ABSTRACT

The breast cancer susceptibility gene 1 (BRCA1) and glutathione S-transferase P1 (GSTP1) promoters are reportedly often methylated in breast cancer tissues. Their methylation status in surrounding normal breast tissues has not been examined thoroughly although this may well be important for a better understanding of breast carcinogenesis. In this study, BRCA1 and GSTP1 promoter methylation was examined by methylation-specific PCR assay. Patients with BRCA1-methylated (n = 15) or BRCA1-unmethylated (n = 15) tumors and those with GSTP1-methylated (n = 9) or GSTP1-unmethylated (n = 11) tumors were included in the present study. Methylation status of manually micro-dissected normal epithelial cells from the formalin-fixed paraffin-embedded sections of normal breast tissues adjacent to and distant from the tumors was examined at multiple sites (n = 1-5). Of the 15 patients with BRCA1-methylated tumors, 9 harbored BRCA1 promoter methylation in at least one site of the normal breast tissues. However, no BRCA1 promoter methylation was observed at any site of the normal tissues of the 15 patients with BRCA1-unmethylated tumors. No GSTP1 promoter methylation was observed in the normal tissues regardless of the methylation status of the tumors. The presence of BRCA1 promoter methylation in the normal tissues was confirmed in the epithelial cells enriched with the magnetic-activated cell sorting method. Our findings suggest that a small proportion of normal breast epithelial cells with BRCA1 promoter methylation can be precursor cells from which BRCA1-methylated breast tumors may originate. This does not apply to GSTP1 promoter methylation.


Subject(s)
BRCA1 Protein/genetics , Breast Neoplasms/genetics , Breast/metabolism , DNA Methylation , Promoter Regions, Genetic , Adult , Aged , BRCA1 Protein/analysis , Epithelial Cells/metabolism , Female , Glutathione S-Transferase pi/analysis , Glutathione S-Transferase pi/genetics , Humans , Immunomagnetic Separation , Middle Aged
7.
Analyst ; 139(4): 786-92, 2014 Feb 21.
Article in English | MEDLINE | ID: mdl-24358460

ABSTRACT

A label-free electrochemical detection of DNA hybridization is used for probing synthetic methylated ssDNA 27-mer or 33-mer targets from the GSTP1-gene. The method is based on electrostatic modulation of the anion-exchange kinetics of a polypyrrole bilayer film deposited on platinum-microelectrodes to which a synthetic single-stranded 15-mer GSTP-1 promoter probe DNA has been attached (DNA detector). The effect of the contact of this DNA-detector with non-methylated and methylated complementary DNA sequences in Tris-buffer is compared using cyclic voltammetry (CV). The DNA-hybridization taking place at the electrode surface leads to a significant decrease of the CV area recorded after exposure to complementary target DNA in comparison to the CV change recorded for non-complementary DNA target. The performance of this miniaturized DNA detector was optimized with respect to hybridization time, temperature, and concentration of the target. It was also evaluated with respect to selectivity, sensitivity, and reproducibility. These results are significant for their possible use as a screening test for hypermethylated DNA sequences.


Subject(s)
DNA Methylation , Electrochemical Techniques , Glutathione S-Transferase pi/analysis , Nucleic Acid Hybridization , Prostatic Neoplasms/diagnosis , Base Sequence , Biomarkers, Tumor/genetics , Biosensing Techniques/methods , DNA/genetics , DNA, Single-Stranded , Electrochemistry/methods , Glutathione S-Transferase pi/genetics , Humans , Male , Microelectrodes , Platinum/chemistry , Polymers/chemistry , Promoter Regions, Genetic , Pyrroles/chemistry , Reproducibility of Results , Sensitivity and Specificity , Static Electricity
8.
Pol J Pathol ; 65(2): 141-6, 2014 Jun.
Article in English | MEDLINE | ID: mdl-25119175

ABSTRACT

Breast carcinoma is the most common cancer and cause of death among females worldwide, including Jordan. The risk factors for breast carcinoma are linked to DNA mutation and failure of DNA repair or detoxification systems. Identification of susceptibility factors that predispose individuals to breast carcinoma if they are exposed to particular environmental agents might give further insight into the etiology of this malignancy. The glutathione S-transferase (GST) enzyme family detoxifies carcinogenic compounds. Several genes that code for these enzymes are polymorphic, with particular genotypes previously shown to confer an increased carcinoma risk. The present study investigates GST-pi polymorphism in 100-tissue samples previously diagnosed as breast carcinoma, and in 48 non-cancer age-matched breast tissues, using the restriction fragment length polymorphism (RFLP) method for the polymerase chain reaction (PCR) product. Among breast cancer cases, 58%, 40% and 2% were homozygous (Ile/Ile), heterozygous (Ile/Val) and homozygous (Val/Val) respectively. In the control group, 58%, 37.5% and 4.2% were homozygous (Ile/Ile), heterozygous (Ile/Val), and homozygous (Val/Val) respectively. Our results did not support the involvement of GST-pi gene polymorphism in susceptibility to breast carcinoma in the tested North Jordanian female population.


Subject(s)
Biomarkers, Tumor/genetics , Breast Neoplasms/enzymology , Breast Neoplasms/genetics , Carcinoma/enzymology , Carcinoma/genetics , Glutathione S-Transferase pi/genetics , Polymorphism, Genetic , Adult , Aged , Biomarkers, Tumor/analysis , Breast Neoplasms/pathology , Carcinoma/pathology , Case-Control Studies , Female , Genetic Predisposition to Disease , Glutathione S-Transferase pi/analysis , Heterozygote , Homozygote , Humans , Immunohistochemistry , Jordan , Middle Aged , Polymerase Chain Reaction , Young Adult
9.
Anticancer Drugs ; 24(4): 394-405, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23388162

ABSTRACT

We present a study of the chemoprotective effects of two caffeic acid phenethyl ester (CAPE)-related structures: LQM717 and LQM706. The modified resistant hepatocyte model in rats was used to study the chemoprevention of these CAPE analogues, which are inexpensive and easily obtained. In the liver cancer model used, we detected extensive necrosis and lipid peroxidation after 24 h, many altered hepatic foci, putatively preneoplastic lesions with γ-glutamyl transpeptidase staining after 30 days, and liver tumors at 12 months. We tested the effect of the CAPE analogues on necrosis, lipid peroxidation, proliferation, p65 activation, altered hepatic foci, and tumors. Both compounds exerted protective effects on lipid peroxidation, necrosis, cell proliferation, p65 activation, and preneoplastic lesions. Rats under a carcinogenic protocol showed a 52, 71.74, and 51.6% decrease in the number of preneoplastic nodules when pretreated with CAPE, LQM706, and LQM717, respectively. At 12 months after carcinogenic treatment, eight of eight rats developed liver cancer, whereas in the group of rats that received pretreatment with CAPE, LQM706, or LQM717, 62.5, 83.3, or 42.85%, respectively, had tumors. In conclusion, LQM717 has the potential to enhance chemoprotection activity much better than CAPE by markedly reducing the formation of liver cancers in this model, and this is a compound that is easy to obtain.


Subject(s)
Acetanilides/pharmacology , Anticarcinogenic Agents/therapeutic use , Antioxidants/therapeutic use , Caffeic Acids/therapeutic use , Cinnamates/therapeutic use , Hepatocytes/drug effects , Liver Neoplasms, Experimental/drug therapy , Phenylethyl Alcohol/analogs & derivatives , Precancerous Conditions/drug therapy , 2-Acetylaminofluorene , Acetanilides/chemical synthesis , Acetanilides/therapeutic use , Animals , Anticarcinogenic Agents/chemical synthesis , Anticarcinogenic Agents/pharmacology , Antioxidants/chemical synthesis , Antioxidants/pharmacology , Caffeic Acids/pharmacology , Carcinogens , Cell Division/drug effects , Cinnamates/chemical synthesis , Cinnamates/pharmacology , Diethylnitrosamine , Drug Evaluation, Preclinical , Drug Resistance , Glutathione S-Transferase pi/analysis , Hepatectomy/adverse effects , Hepatocytes/chemistry , Hepatocytes/pathology , Ki-67 Antigen/analysis , Lipid Peroxidation/drug effects , Liver Neoplasms, Experimental/chemically induced , Liver Neoplasms, Experimental/pathology , Male , Molecular Structure , Phenylethyl Alcohol/pharmacology , Phenylethyl Alcohol/therapeutic use , Precancerous Conditions/chemically induced , Precancerous Conditions/pathology , Rats , Rats, Inbred F344 , Transcription Factor RelA/antagonists & inhibitors , Transcription Factor RelA/metabolism
10.
Hepatogastroenterology ; 59(113): 130-3, 2012.
Article in English | MEDLINE | ID: mdl-21940361

ABSTRACT

BACKGROUND/AIMS: The aim of this study was to determine whether expression of the excision repair cross complementing protein (ERCC1), glutathione S-transferase pi (GST-p) and thymidylate synthase (TS) predict response in patients with advanced colorectal cancer treated with 5-fluorouracil/oxaliplatin chemotherapy. METHODOLOGY: The study population consisted of 39 patients with advanced colorectal cancer (median age, 65 years). Patients were treated with the modified FOLFOX 6 regimen. The expression of ERCC-1, GST-p and TS of primary tumors were examined by immunohistochemistry. RESULTS: The response rate of modified FOLFOX 6 chemotherapy was 51.3%. The positive rates of ERCC-1, GST-p and TS were 43.6%, 33.3% and 66.7%, respectively. The patients without ERCC-1 (p=0.0248) or GST-p? (p=0.0019) expression were more likely to respond to chemotherapy. TS expression did not correlate with chemotherapeutic response. CONCLUSIONS: Immunohistochemical studies for ERCC-1 and GST-p may be useful in prediction of the response to 5-fluorouracil/oxaliplatin chemotherapy in advanced colorectal cancer patients.


Subject(s)
Adenocarcinoma/drug therapy , Adenocarcinoma/enzymology , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Biomarkers, Tumor/analysis , Colorectal Neoplasms/drug therapy , Colorectal Neoplasms/enzymology , DNA-Binding Proteins/analysis , Endonucleases/analysis , Glutathione S-Transferase pi/analysis , Adenocarcinoma/pathology , Adult , Aged , Aged, 80 and over , Colorectal Neoplasms/pathology , Female , Fluorouracil/administration & dosage , Humans , Immunohistochemistry , Japan , Leucovorin/administration & dosage , Logistic Models , Male , Middle Aged , Multivariate Analysis , Organoplatinum Compounds/administration & dosage , Patient Selection , Predictive Value of Tests , Retrospective Studies , Risk Assessment , Risk Factors , Thymidylate Synthase/analysis , Treatment Outcome
11.
Cancer Sci ; 102(1): 88-94, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20964789

ABSTRACT

The carcinogenicity of the low amounts of genotoxic carcinogens present in food is of pressing concern. The purpose of the present study was to determine the carcinogenicity of low doses of the dietary genotoxic carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and to investigate mechanisms by which IQ exerts its carcinogenic effects. A total of 1595 male F344 rats were divided into seven groups and administered with IQ at doses of 0, 0.001, 0.01, 0.1, 1, 10 and 100 p.p.m. in the diet for 16 weeks. We found that IQ doses of 1 p.p.m. and below did not induce preneoplastic lesions in either the liver or the colon, while IQ doses of 10 and 100 p.p.m. induced preneoplastic lesions in both of these organs. These results demonstrate the presence of no-effect levels of IQ for both liver and colon carcinogenicity in rats. The finding that p21(Cip/WAF1) was significantly induced in the liver at doses well below those required for IQ mediated carcinogenic effects suggests that induction of p21(Cip/WAF1) is one of the mechanisms responsible for the observed no-effect of low doses of IQ. Furthermore, IQ administration caused significant induction of CYP1A2 at doses of 0.01-10 p.p.m., but administration of 100 p.p.m. IQ induced CYP1A1 rather than CYP1A2. This result indicates the importance of dosage when interpreting data on the carcinogenicity and metabolic activation of IQ. Overall, our results suggest the existence of no-effect levels for the carcinogenicity of this genotoxic compound.


Subject(s)
Carcinogens/toxicity , Cyclin-Dependent Kinase Inhibitor p21/physiology , Quinolines/toxicity , Aberrant Crypt Foci/chemically induced , Animals , Cell Cycle Proteins/physiology , DNA Adducts/metabolism , DNA-(Apurinic or Apyrimidinic Site) Lyase/physiology , Glutathione S-Transferase pi/analysis , Liver/metabolism , Male , Nuclear Proteins/physiology , Rats , Rats, Inbred F344
12.
Cancer Sci ; 101(5): 1093-8, 2010 May.
Article in English | MEDLINE | ID: mdl-20180811

ABSTRACT

Peroxisome proliferators (PP), including clofibrate (CF), are non-genotoxic rodent carcinogens, and oxidative DNA damages are suggested as a causative event for carcinogenesis. Gene expression profiles differ between hepatic lesions induced by PP and genotoxic carcinogens. Our previous study revealed that expression of L-bifunctional enzyme (enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase, BE) was repressed in preneoplastic lesions induced by PP, whereas it was enhanced in the surrounding tissues. In the present study, we immunohistochemically examined expression of the specific glutathione S-transferase (GST) form, GST-A4, which detoxifies 4-hydroxy-alkenal, the end-product of lipid peroxides, and nuclear factor-erythroid 2-related factor 2 (Nrf2), a transcription factor for many genes encoding drug-metabolizing enzymes and defending enzymes against oxidative stress, during rat hepatocarcinogenesis induced by CF and genotoxic carcinogens. GST-A4 and Nrf2 were not expressed in BE-negative foci at 8 weeks of CF administration, but were expressed in the foci at 60 weeks. GST-A4-positive foci appeared at later stages than BE-negative foci, but its localization was coincidental with that of the latter foci. The areas of GST-A4-positive foci were larger than those of BE-negative foci without GST-A4 expression. Most GST-A4-positive foci were also positive for Nrf2. In rat livers induced by genotoxic carcinogens, GST-P-negative foci as well as GST-P-positive foci were demonstrated. GST-A4 and Nrf2 were expressed in GST-P-negative foci, whereas they were not expressed in most GST-P-positive foci. Thus, GST-A4-positive foci developed in rat livers by CF and genotoxic carcinogen administration, indicating that the enzyme is a positive marker for hepatic foci induced by these different carcinogens.


Subject(s)
Biomarkers, Tumor/analysis , Clofibrate/toxicity , Glutathione Transferase/analysis , Liver Neoplasms, Experimental/enzymology , Precancerous Conditions/enzymology , Animals , Glutathione S-Transferase pi/analysis , Immunohistochemistry , Liver/drug effects , Liver/pathology , Liver Neoplasms, Experimental/etiology , NF-E2-Related Factor 2/analysis , Precancerous Conditions/etiology , Rats
14.
J Nutr ; 140(8): 1404-10, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20554899

ABSTRACT

Many phytochemicals possess cancer-preventive properties, some putatively through phase II metabolism-mediated mutagen/oxidant quenching. We applied human lung cells in vitro to investigate the effects of several candidate phytopreventive agents, including green tea extracts (GTE), broccoli sprout extracts (BSE), epigallocatechin gallate (EGCG), sulforaphane (SFN), phenethyl isothiocyanate (PEITC), and benzyl isothiocyanate (BITC), on inducing phase II enzymes glutathione S-transferase P1 (GSTP1) and NAD(P)H:quinone oxidoreductase 1 (NQO1) at mRNA and protein levels. Primary normal human bronchial epithelial cells (NHBE), immortalized human bronchial epithelial cells (HBEC), and lung adenocarcinoma cells (A549) were exposed to diet-achievable levels of GTE and BSE (0.5, 1.0, 2.0 mg/L), or individual index components EGCG, SFN, PEITC, BITC (0.5, 1.0, 2.0 micromol/L) for 24 h, 48 h, and 6 d, respectively. mRNA assays employed RNA-specific quantitative RT-PCR and protein assays employed Western blotting. We found that in NHBE cells, while GSTP1 mRNA levels were slightly but significantly increased after exposure to GTE or BSE, NQO1 mRNA increased to 2- to 4-fold that of control when exposed to GTE, BSE, or SFN. Effects on NQO1 mRNA expression in HBEC cells were similar. NQO1 protein expression increased up to 11.8-fold in SFN-treated NHBE cells. Both GSTP1 and NQO1 protein expression in A549 cells were constitutively high but not induced under any condition. Our results suggest that NQO1 is more responsive to the studied chemopreventive agents than GSTP1 in human lung cells and there is discordance between single agent and complex mixture effects. We conclude that modulation of lung cell phase II metabolism by chemopreventive agents requires cell- and agent-specific discovery and testing.


Subject(s)
Anticarcinogenic Agents/pharmacology , Glutathione S-Transferase pi/genetics , Lung/enzymology , NAD(P)H Dehydrogenase (Quinone)/genetics , Plant Extracts/pharmacology , Brassica/chemistry , Bronchi , Camellia sinensis/chemistry , Catechin/analogs & derivatives , Catechin/pharmacology , Cell Division/drug effects , Cell Line , Cell Line, Tumor , Epithelial Cells , Gene Expression/drug effects , Glutathione S-Transferase pi/analysis , Humans , Isothiocyanates/pharmacology , Lung Neoplasms , NAD(P)H Dehydrogenase (Quinone)/analysis , Plant Extracts/chemistry , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction , Sulfoxides , Thiocyanates/pharmacology
15.
Toxicol Pathol ; 38(1): 182-7, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20080933

ABSTRACT

The Ito Liver Model and the Ito Multi-organ Model are used in conjunction and constitute an efficient and rapid bioassay for the identification of both genotoxic and nongenotoxic carcinogenic chemicals. The Ito Liver Model is an 8-week bioassay system that uses the number and size of foci of hepatocytes positive for glutathione S-transferase placental form (GST-P) as the end-point marker. One hundred fifty-nine compounds were tested using the Ito Liver Model: 61 of 66 hepatocarcinogens tested positive, and 10 of 43 nonliver carcinogens were also positive. The false-positive detection of noncarcinogens was low; a single false-positive result was obtained from the 50 noncarcinogens tested. Since more than half of all known carcinogens are hepatocarcinogens in rodents, the initial 8-week bioassay is able to detect most carcinogens. The Ito Multi-organ Model is a 28-week bioassay system for the detection of carcinogens that were not identified by the Ito Liver Model. Results are evaluated by preneoplastic and neoplastic lesions in major organs. Forty-four compounds were tested using the Ito Multi-organ Model: 17 out of 17 liver carcinogens were positive, and 19 out of 22 (86%) nonliver carcinogens were positive. None of the five noncarcinogens tested positive.


Subject(s)
Carcinogenicity Tests/methods , Disease Models, Animal , Liver Neoplasms, Experimental/chemically induced , Animals , Glutathione S-Transferase pi/analysis , Male , Rats , Rats, Inbred F344
16.
Int J Colorectal Dis ; 25(12): 1397-405, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20714737

ABSTRACT

BACKGROUND AND AIM: The aim of the present work was to analyze the expression of antioxidant enzymes GST-pi, SOD1, and SOD2 in endocrine cells of colorectal cancers and to evaluate the significance of the presence of thus labeled endocrine cells as prognostic factor. METHODS: The expression of chromogranin A (ChGA), GST-pi, SOD1, and SOD2 was determined in endocrine cells of 128 colorectal cancers using light and electron immunohistochemistry and double immunogold labeling method. RESULTS: Endocrine cells expressing at least one of the studied antioxidant enzymes were detected in a relatively small proportion of primary colorectal cancers (22 cases, 17%; 14% GST-pi-positive, 14% SOD1-positive, and 9% SOD2-positive). The double immunogold staining and the following electron microscopy showed that GST-pi, SOD1, and SOD2 were co-localized with ChGA to the granules of most endocrine cells. The survival analyses revealed that patients with endocrine cells in primary tumor tissues expressing GST-pi had worse prognosis after the surgical therapy than those without GST-pi-positive endocrine cells (median of 22.70 vs. 49.43 months, p < 0.05, Log-rank test). CONCLUSIONS: Most of the ChGA-positive endocrine cells in colorectal cancers also expressed some or all of the three studied antioxidant enzymes, GST-pi, SOD1, and SOD2. Moreover, patients having tumors with GST-pi-positive endocrine cells have an unfavorable prognosis. We suggest that not the neuroendocrine differentiation in general, but the presence in the tumors of endocrine cells with activated antioxidant defense and probably metabolically more active might determine a more aggressive type of cancer leading to worse prognosis for patients.


Subject(s)
Colorectal Neoplasms/enzymology , Endocrine Cells/enzymology , Gene Expression Regulation, Neoplastic , Glutathione S-Transferase pi/analysis , Superoxide Dismutase/analysis , Antioxidants , Cell Line, Tumor , Chromogranin A/analysis , Chromogranin A/genetics , Colorectal Neoplasms/mortality , Colorectal Neoplasms/pathology , Endocrine Cells/pathology , Gene Expression Regulation, Enzymologic , Glutathione S-Transferase pi/genetics , Humans , Immunohistochemistry , Prognosis , Reactive Oxygen Species/metabolism , Superoxide Dismutase/genetics , Survival Analysis , Xenobiotics/metabolism
17.
Cancer Biol Med ; 17(4): 1014-1025, 2020 11 15.
Article in English | MEDLINE | ID: mdl-33299650

ABSTRACT

Objective: The aim of the study was to identify specific chemosensitivity drugs for various molecular subtypes of breast tumors in Chinese women, by detecting the expression of drug resistance genes and by using the drug sensitivity test on different molecular subtypes of breast cancers. Methods: The expression of drug resistance genes including Topo II, GST-π, P-gp, LRP, and CD133 were detected with immunohistochemistry in a tissue microarray. Drug sensitivity tests included those for paclitaxel, epirubicin, carboplatin, vinorelbine, and fluorouracil and were conducted on primary cancer tissue cells and cell lines, including the T47D, BT-474, and MDA-MB-231 cells and human breast cancer xenografts in nude mice. Results: The different drug resistant genes Topo II, GST-π, P-gp, and LRP were differentially expressed among different molecular subtypes of breast cancers (P < 0.05). Positive expression of CD133 was highest in basal-like breast cancer (P < 0.05). Kaplan-Meier survival analysis showed that positive expressions of Topo II and CD133 both correlated with shorter disease-free survival (DFS) (P < 0.05) and overall survival (P < 0.05), and positive expression of LRP correlated only with shorter DFS (P < 0.05). BT-474 showed chemosensitivity to paclitaxel and epirubicin, while MDA-MB-231 showed chemosensitivities to paclitaxel, epirubicin, carboplatin, and fluorouracil (T/C ≤ 50%). The basal-like and HER2+ breast cancer primary cells showed chemosensitivities to paclitaxel and epirubicin with significant differences compared with luminal breast cancer primary cells (P < 0.05). Conclusions: The differential expression of drug resistance genes and the differential chemosensitivities of drugs in different molecular subtype of breast cancers suggested that individual treatment should be given for each type of breast cancer.


Subject(s)
Breast Neoplasms/chemistry , Drug Resistance, Neoplasm/genetics , AC133 Antigen/analysis , ATP Binding Cassette Transporter, Subfamily B, Member 1/analysis , Animals , Antineoplastic Agents, Phytogenic/therapeutic use , Biomarkers, Tumor/analysis , Breast Neoplasms/drug therapy , Breast Neoplasms/mortality , Carboplatin/therapeutic use , China , DNA Topoisomerases, Type II/analysis , Epirubicin/therapeutic use , Female , Fluorouracil/therapeutic use , Glutathione S-Transferase pi/analysis , Humans , Immunohistochemistry , Mice , Mice, Inbred BALB C , Mice, Nude , Paclitaxel/therapeutic use , Survival Analysis , Vinorelbine/therapeutic use , Xenograft Model Antitumor Assays
18.
Toxicol In Vitro ; 23(4): 674-9, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19490842

ABSTRACT

The aim of this study was to find out the profile of cellular glutathione (GSH) and GSH S-transferase (GST) in hepatocytes differentiated from adult mesenchymal stem cells (MSC). For this purpose, we have derived functionally active hepatocyte-like cells from normal human multipotent adult MSC. Then the differentiated cells were characterized by specific hepatic markers. The cellular GSH and GST catalytic activity toward 1-chloro-2,4-dinitrobenzene (CDNB) were determined in hepatocyte-like cells differentiated from MSC compared with undifferentiated MSC. Reverse transcription polymerase chain reaction (RT-PCR) and immunoblotting techniques were used to study GST-P1-1 and GST-A1-1 expression in differentiated and undifferentiated cells. The results showed that there is more than threefold increase in GST catalytic activity in hepatocytes recovered by day 14 of differentiation. GST-P1-1 mRNA expression was detected in both differentiated hepatocyte-like cells and their undifferentiated progenitors. Under similar conditions, only differentiated hepatocyte-like cells expressed GST-A1-1 mRNA. These results were further confirmed by showing that the undifferentiated cells expressed both GST-A and GST-P proteins. Unlike GST, the level of cellular GSH was declined (approximately 20%) in hepatocytes derived from MSC as compared to that of undifferentiated cells. These data may suggest that hepatogenic differentiation of human bone marrow MSC is accompanied with the regulation of factors participating in GSH conjugation pathway.


Subject(s)
Bone Marrow Cells/cytology , Glutathione S-Transferase pi/genetics , Glutathione Transferase/genetics , Hepatocytes/enzymology , Isoenzymes/genetics , Mesenchymal Stem Cells/cytology , RNA, Messenger/analysis , Cell Differentiation , Cells, Cultured , Glutathione/analysis , Glutathione S-Transferase pi/analysis , Glutathione Transferase/analysis , Hepatocytes/cytology , Humans , Isoenzymes/analysis
19.
Talanta ; 204: 633-640, 2019 Nov 01.
Article in English | MEDLINE | ID: mdl-31357346

ABSTRACT

Fluorogenic substrates are used to visualize the activity of cancer-associated enzymes and to interpret biological events. Certain types of glutathione S-transferase (GST), such as Pi class GST (referred to as GSTP1), are more highly expressed in a wide variety of human cancer tissues compared to their corresponding normal tissues. Pi class GST is thus a cancer cell molecular marker and potential target for overcoming resistance to chemotherapy. Here, we report that 4-bromo-1,8-naphthalimide (BrNaph) is a practical fluorogenic GST substrate. We have found that HE-BrNaph, an N-hydroxyethyl derivative, shows remarkable fluorescence enhancement upon GST-catalyzed SNAr replacement of the bromo group with a glutathionyl group. This substitution was highly selective and occurred only in the presence of GSH/GSTs; no non-enzymatic reaction was observed. We demonstrated that HE-BrNaph allows visualization of GST activity in living cells and enables to distinguish cancer cells from normal cells. Further, various N-substitutions in BrNaph retain susceptibility to enzymatic activity and isozyme selectivity, suggesting the applicability of BrNaph derivatives. Thus, BrNaph and its derivatives are GST substrates useful for fluorescence imaging and the intracellular detection of GSTP1 activity in living cells.


Subject(s)
Fluorescent Dyes/chemistry , Glutathione S-Transferase pi/analysis , Naphthalimides/chemistry , Cell Line, Tumor , Enzyme Assays/methods , Fluorescent Dyes/chemical synthesis , Fluorescent Dyes/toxicity , Glutathione S-Transferase pi/chemistry , Humans , Kinetics , Microscopy, Confocal/methods , Microscopy, Fluorescence/methods , Naphthalimides/chemical synthesis , Naphthalimides/toxicity , Neoplasms/diagnosis
20.
Cancer Invest ; 26(4): 344-51, 2008 May.
Article in English | MEDLINE | ID: mdl-18443954

ABSTRACT

AIM: Multidrug resistance (MDR) is closely correlated to an unfavorable prognosis in various human cancers. However, the clinical significance of the expression of MDR-related proteins p-glycoprotein (PGP), glutathione-s-transferases (GST-pi), topoisomerase-II (Topo-II) and lung resistance protein (LRP) in primary gastric cardiac adenocarcinoma (PGCA) remains unclear. In this present study, the total of the four kinds of MDR-related proteins mentioned above were detected by using immunohistochemistry, and their clinical significance in chemoresistance were also investigated. METHODS: This retrospective study included 69 resected specimens from patients with PGCA. The expression of PGP, GST-pi, Topo-II and LRP in formalin-fixed paraffin-embedded tissue sections was determined by a labelled streptavidin-biotin immunohistochemical technique, and the results were analyzed in correlation with clinicopathological data. None of these patients received chemotherapy prior to surgery. RESULTS: The positive rates of expression of PGP, GST-pi, Topo-II and LRP in malignant tissues (49.2%, 75.4%, 68.1% and 58%, respectively) were all higher than that of the normal tissues(0, 30%, 20% and 0, respectively, P < 0.01). PGP expression in tumors that had metastasized was significantly more frequent than in tumors that had not metastasized (67.5% vs 24.1%, P < 0.01). The expression of PGP was closely related with clinicopathologic staging (staging 1/2 vs 3/4, 28.6% vs 58.3%, P < 0.05). No significant correlation was shown between PGP and increasing differentiated degree (40%, 42.4% and 61.5%, P > 0.05). GST-pi expression status progressively increased with increasing differentiated degree (40%, 75.8% and 88.5%, P < 0.05) and clinicopathologic stage (staging 1/2 vs 3/4, 57.1% vs 83.3%, P < 0.05). In addition, a significant positive correlation was also observed between GST-pi and lymphatic metastasis (with vs. without metastasis, 87.5% vs 58.6%, P < 0.05). The expression of Topo-II was associated with increasing differentiated degree (33.3%, 69.7 and 80.7%, P < 0.01). No significant differences with Topo-II expression were found in relation to the clinicopathologic stage (staging 1/2 vs 3/4, 57.1% vs 72.9%, P > 0.05) and lymphatic metastasis (with vs. without metastasis, 65.0% vs 72.4%, P > 0.05). Moreover, a significant difference with the expression of LRP was found in relation to the clinicopathologic stage (staging 1/2 vs 3/4, 38% vs 66.6%, P < 0.05), and lymphatic metastasis (with vs without metastasis, 70.0% vs 41.4%, P < 0.05). Comparing the well, moderately and poorly differentiated cohort, a non-statistical increasing trend towards LRP expression status was noted (50.0%, 54.5% and 65.3%, respectively, P > 0.05). Besides, the co-expression of all four tested MDR-related proteins also existed. The positive rates of co-expression of PGP and GST-pi, PGP and Topo-II, PGP and LRP, GST-pi and Topo-II, LRP and GST-pi, LRP and Topo-II, PGP, GST-pi, Topo-II and LRP in malignant cells were 23.2%, 15.9%, 11.6%, 13.0, 26.1, 7.24, 5.8, respectively. CONCLUSIONS: MDR-related proteins PGP, GST-pi, Topo-II alpha and LRP are involved in multiple mechanisms of drug resistance in PGCA. Combined determination of PGP, GST-pi, Topo-II and LRP may be prospectively valuable for optimizing the chemotherapy regimes, developing high quality anti-cancer drugs, and further predicting the outcomes of those patients with PGCA.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/analysis , Adenocarcinoma/chemistry , Cardia/chemistry , DNA Topoisomerases, Type II/analysis , Drug Resistance, Multiple/genetics , Drug Resistance, Neoplasm/genetics , Gene Expression Regulation, Neoplastic , Glutathione S-Transferase pi/analysis , Neoplasm Proteins/analysis , Stomach Neoplasms/chemistry , Vault Ribonucleoprotein Particles/metabolism , ATP Binding Cassette Transporter, Subfamily B, Member 1/biosynthesis , ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics , Adenocarcinoma/genetics , Adenocarcinoma/metabolism , Adenocarcinoma/secondary , Adult , Aged , Cardia/pathology , DNA Topoisomerases, Type II/biosynthesis , DNA Topoisomerases, Type II/genetics , Female , Glutathione S-Transferase pi/biosynthesis , Glutathione S-Transferase pi/genetics , Humans , Immunoenzyme Techniques , Lymphatic Metastasis , Male , Middle Aged , Neoplasm Proteins/biosynthesis , Neoplasm Proteins/genetics , Neoplasm Staging , Organelles/chemistry , Retrospective Studies , Stomach Neoplasms/genetics , Stomach Neoplasms/metabolism , Stomach Neoplasms/pathology , Vault Ribonucleoprotein Particles/biosynthesis , Vault Ribonucleoprotein Particles/genetics
SELECTION OF CITATIONS
SEARCH DETAIL